Involvement of intrinsic mitochondrial pathway in neosergeolide-induced apoptosis of human HL-60 leukemia cells: The role of mitochondrial permeability transition pore and DNA damage

Detalhes bibliográficos
Autor(a) principal: Coelho Cavalcanti, Bruno
Data de Publicação: 2012
Outros Autores: Costa, Patrícia Marçal da, Carvalho, Adriana Andrade Carvalho, Rodrigues, Francisco Augusto Rocha Santos, Amorim, Rodrigo C.N., Silva, Ellen Cristina Costa, Pohlit, Adrian Martin, Costa-Lotufo, Leticia Veras, Moraes, Manœl Odorico de, Pessoa, Cláudia do Ó.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional do INPA
Texto Completo: https://repositorio.inpa.gov.br/handle/1/16120
Resumo: Context: Quassinoids are biologically active secondary metabolites found exclusively in the Simaroubaceae family of plants. These compounds generally present important biological properties, including cytotoxic and antitumor properties. Objective: In the present study, the cytotoxic effects of neosergeolide, a quassinoid isolated from Picrolemma sprucei Hook. f., were evaluated in human promyelocytic leukemia cells (HL-60). Materials and methods: Cytotoxicity and antiproliferative effects were evaluated by the MTT assay, May-Grünwald-Giemsa's staining, BrdU incorporation test, and flow cytometry procedures. The comet assay and micronuclei analysis were applied to determine the genotoxic and mutagenic potential of neosergeolide. Results: After 24h exposure, neosergeolide strongly inhibited cancer cell proliferation (IC 50 0.1 μM), and its activity seemed to be selective to tumor cells because it had no antiproliferative effect on human peripheral blood mononuclear cells (PBMC) at tested concentrations. Apoptosis was induced at submicromolar concentrations (0.05, 0.1, and 0.2 μM) as evidenced by morphological changes, mitochondrial depolarization, phosphatidylserine externalization, caspases activation, and internucleosomal DNA fragmentation. Additionally, neosergeolide effects were prevented by cyclosporine A (CsA), an inhibitor of the mitochondrial permeability transition (MPT) pore, which reinforced the participation of intrinsic pathways in the apoptotic process induced by this natural quassinoid. Direct DNA damage was further confirmed by comet assay and cytokinesis-block micronucleus test. Discussion and conclusion: The present study provided experimental evidence to support the underlying mechanism of action involved in the neosergeolide-mediated apoptosis. In addition, no antiproliferative effect or DNA damage effect of neosergeolide was evident in PBMC, highlighting its therapeutic potential. © 2012 Informa Healthcare USA, Inc.
id INPA-2_0909b83d44c6799a603a6a7ff23c6435
oai_identifier_str oai:repositorio:1/16120
network_acronym_str INPA-2
network_name_str Repositório Institucional do INPA
repository_id_str
spelling Coelho Cavalcanti, BrunoCosta, Patrícia Marçal daCarvalho, Adriana Andrade CarvalhoRodrigues, Francisco Augusto Rocha SantosAmorim, Rodrigo C.N.Silva, Ellen Cristina CostaPohlit, Adrian MartinCosta-Lotufo, Leticia VerasMoraes, Manœl Odorico dePessoa, Cláudia do Ó.2020-05-24T21:49:10Z2020-05-24T21:49:10Z2012https://repositorio.inpa.gov.br/handle/1/1612010.3109/13880209.2012.654921Context: Quassinoids are biologically active secondary metabolites found exclusively in the Simaroubaceae family of plants. These compounds generally present important biological properties, including cytotoxic and antitumor properties. Objective: In the present study, the cytotoxic effects of neosergeolide, a quassinoid isolated from Picrolemma sprucei Hook. f., were evaluated in human promyelocytic leukemia cells (HL-60). Materials and methods: Cytotoxicity and antiproliferative effects were evaluated by the MTT assay, May-Grünwald-Giemsa's staining, BrdU incorporation test, and flow cytometry procedures. The comet assay and micronuclei analysis were applied to determine the genotoxic and mutagenic potential of neosergeolide. Results: After 24h exposure, neosergeolide strongly inhibited cancer cell proliferation (IC 50 0.1 μM), and its activity seemed to be selective to tumor cells because it had no antiproliferative effect on human peripheral blood mononuclear cells (PBMC) at tested concentrations. Apoptosis was induced at submicromolar concentrations (0.05, 0.1, and 0.2 μM) as evidenced by morphological changes, mitochondrial depolarization, phosphatidylserine externalization, caspases activation, and internucleosomal DNA fragmentation. Additionally, neosergeolide effects were prevented by cyclosporine A (CsA), an inhibitor of the mitochondrial permeability transition (MPT) pore, which reinforced the participation of intrinsic pathways in the apoptotic process induced by this natural quassinoid. Direct DNA damage was further confirmed by comet assay and cytokinesis-block micronucleus test. Discussion and conclusion: The present study provided experimental evidence to support the underlying mechanism of action involved in the neosergeolide-mediated apoptosis. In addition, no antiproliferative effect or DNA damage effect of neosergeolide was evident in PBMC, highlighting its therapeutic potential. © 2012 Informa Healthcare USA, Inc.Volume 50, Número 8, Pags. 980-993Attribution-NonCommercial-NoDerivs 3.0 Brazilhttp://creativecommons.org/licenses/by-nc-nd/3.0/br/info:eu-repo/semantics/openAccessAntineoplastic AgentCaspase 3Caspase 7Caspase 9Cyclosporin ADoxorubicinNeosergeolidePhosphatidylserineQuassinoid DerivativeReactive Oxygen MetaboliteUnclassified DrugAntiproliferative ActivityApoptosisCancer InhibitionCell Cycle G0 PhaseCell Cycle G1 PhaseCell Cycle G2 PhaseCell Cycle M PhaseCell Cycle S PhaseCell DifferentiationCell ProliferationCell Strain Hl 60Cell StructureCell ViabilityConcentration ResponseControlled StudyDepolarizationDna ContentDna DamageDna FragmentationDrug EffectDrug MechanismEnzyme ActivationGenotoxicityHumanHuman CellIc 50Leukemia CellMembrane Potential, MitochondrialMitochondrial PermeabilityMutagenic ActivityOxidative StressPeripheral Blood Mononuclear CellPromyelocytic LeukemiaAntineoplastic Agents, PhytogenicApoptosisCell ProliferationCells, CulturedComet AssayCyclosporineCytokinesisDna FragmentationHl-60 CellsHumansInhibitory Concentration 50Leukemia, Promyelocytic, AcuteLeukocytes, MononuclearMembrane Potential, MitochondrialMicronucleus TestsMitochondriaMitochondrial Membrane Transport ProteinsNeoplasm ProteinsQuassinsSimaroubaceaePicrolemmaSimaroubaceaeInvolvement of intrinsic mitochondrial pathway in neosergeolide-induced apoptosis of human HL-60 leukemia cells: The role of mitochondrial permeability transition pore and DNA damageinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlePharmaceutical Biologyengreponame:Repositório Institucional do INPAinstname:Instituto Nacional de Pesquisas da Amazônia (INPA)instacron:INPAORIGINALartigo-inpa.pdfartigo-inpa.pdfapplication/pdf1333962https://repositorio.inpa.gov.br/bitstream/1/16120/1/artigo-inpa.pdf00f54b40fae7965294bff41217a581f3MD511/161202020-05-24 17:58:45.209oai:repositorio:1/16120Repositório de PublicaçõesPUBhttps://repositorio.inpa.gov.br/oai/requestopendoar:2020-05-24T21:58:45Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA)false
dc.title.en.fl_str_mv Involvement of intrinsic mitochondrial pathway in neosergeolide-induced apoptosis of human HL-60 leukemia cells: The role of mitochondrial permeability transition pore and DNA damage
title Involvement of intrinsic mitochondrial pathway in neosergeolide-induced apoptosis of human HL-60 leukemia cells: The role of mitochondrial permeability transition pore and DNA damage
spellingShingle Involvement of intrinsic mitochondrial pathway in neosergeolide-induced apoptosis of human HL-60 leukemia cells: The role of mitochondrial permeability transition pore and DNA damage
Coelho Cavalcanti, Bruno
Antineoplastic Agent
Caspase 3
Caspase 7
Caspase 9
Cyclosporin A
Doxorubicin
Neosergeolide
Phosphatidylserine
Quassinoid Derivative
Reactive Oxygen Metabolite
Unclassified Drug
Antiproliferative Activity
Apoptosis
Cancer Inhibition
Cell Cycle G0 Phase
Cell Cycle G1 Phase
Cell Cycle G2 Phase
Cell Cycle M Phase
Cell Cycle S Phase
Cell Differentiation
Cell Proliferation
Cell Strain Hl 60
Cell Structure
Cell Viability
Concentration Response
Controlled Study
Depolarization
Dna Content
Dna Damage
Dna Fragmentation
Drug Effect
Drug Mechanism
Enzyme Activation
Genotoxicity
Human
Human Cell
Ic 50
Leukemia Cell
Membrane Potential, Mitochondrial
Mitochondrial Permeability
Mutagenic Activity
Oxidative Stress
Peripheral Blood Mononuclear Cell
Promyelocytic Leukemia
Antineoplastic Agents, Phytogenic
Apoptosis
Cell Proliferation
Cells, Cultured
Comet Assay
Cyclosporine
Cytokinesis
Dna Fragmentation
Hl-60 Cells
Humans
Inhibitory Concentration 50
Leukemia, Promyelocytic, Acute
Leukocytes, Mononuclear
Membrane Potential, Mitochondrial
Micronucleus Tests
Mitochondria
Mitochondrial Membrane Transport Proteins
Neoplasm Proteins
Quassins
Simaroubaceae
Picrolemma
Simaroubaceae
title_short Involvement of intrinsic mitochondrial pathway in neosergeolide-induced apoptosis of human HL-60 leukemia cells: The role of mitochondrial permeability transition pore and DNA damage
title_full Involvement of intrinsic mitochondrial pathway in neosergeolide-induced apoptosis of human HL-60 leukemia cells: The role of mitochondrial permeability transition pore and DNA damage
title_fullStr Involvement of intrinsic mitochondrial pathway in neosergeolide-induced apoptosis of human HL-60 leukemia cells: The role of mitochondrial permeability transition pore and DNA damage
title_full_unstemmed Involvement of intrinsic mitochondrial pathway in neosergeolide-induced apoptosis of human HL-60 leukemia cells: The role of mitochondrial permeability transition pore and DNA damage
title_sort Involvement of intrinsic mitochondrial pathway in neosergeolide-induced apoptosis of human HL-60 leukemia cells: The role of mitochondrial permeability transition pore and DNA damage
author Coelho Cavalcanti, Bruno
author_facet Coelho Cavalcanti, Bruno
Costa, Patrícia Marçal da
Carvalho, Adriana Andrade Carvalho
Rodrigues, Francisco Augusto Rocha Santos
Amorim, Rodrigo C.N.
Silva, Ellen Cristina Costa
Pohlit, Adrian Martin
Costa-Lotufo, Leticia Veras
Moraes, Manœl Odorico de
Pessoa, Cláudia do Ó.
author_role author
author2 Costa, Patrícia Marçal da
Carvalho, Adriana Andrade Carvalho
Rodrigues, Francisco Augusto Rocha Santos
Amorim, Rodrigo C.N.
Silva, Ellen Cristina Costa
Pohlit, Adrian Martin
Costa-Lotufo, Leticia Veras
Moraes, Manœl Odorico de
Pessoa, Cláudia do Ó.
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Coelho Cavalcanti, Bruno
Costa, Patrícia Marçal da
Carvalho, Adriana Andrade Carvalho
Rodrigues, Francisco Augusto Rocha Santos
Amorim, Rodrigo C.N.
Silva, Ellen Cristina Costa
Pohlit, Adrian Martin
Costa-Lotufo, Leticia Veras
Moraes, Manœl Odorico de
Pessoa, Cláudia do Ó.
dc.subject.eng.fl_str_mv Antineoplastic Agent
Caspase 3
Caspase 7
Caspase 9
Cyclosporin A
Doxorubicin
Neosergeolide
Phosphatidylserine
Quassinoid Derivative
Reactive Oxygen Metabolite
Unclassified Drug
Antiproliferative Activity
Apoptosis
Cancer Inhibition
Cell Cycle G0 Phase
Cell Cycle G1 Phase
Cell Cycle G2 Phase
Cell Cycle M Phase
Cell Cycle S Phase
Cell Differentiation
Cell Proliferation
Cell Strain Hl 60
Cell Structure
Cell Viability
Concentration Response
Controlled Study
Depolarization
Dna Content
Dna Damage
Dna Fragmentation
Drug Effect
Drug Mechanism
Enzyme Activation
Genotoxicity
Human
Human Cell
Ic 50
Leukemia Cell
Membrane Potential, Mitochondrial
Mitochondrial Permeability
Mutagenic Activity
Oxidative Stress
Peripheral Blood Mononuclear Cell
Promyelocytic Leukemia
Antineoplastic Agents, Phytogenic
Apoptosis
Cell Proliferation
Cells, Cultured
Comet Assay
Cyclosporine
Cytokinesis
Dna Fragmentation
Hl-60 Cells
Humans
Inhibitory Concentration 50
Leukemia, Promyelocytic, Acute
Leukocytes, Mononuclear
Membrane Potential, Mitochondrial
Micronucleus Tests
Mitochondria
Mitochondrial Membrane Transport Proteins
Neoplasm Proteins
Quassins
Simaroubaceae
Picrolemma
Simaroubaceae
topic Antineoplastic Agent
Caspase 3
Caspase 7
Caspase 9
Cyclosporin A
Doxorubicin
Neosergeolide
Phosphatidylserine
Quassinoid Derivative
Reactive Oxygen Metabolite
Unclassified Drug
Antiproliferative Activity
Apoptosis
Cancer Inhibition
Cell Cycle G0 Phase
Cell Cycle G1 Phase
Cell Cycle G2 Phase
Cell Cycle M Phase
Cell Cycle S Phase
Cell Differentiation
Cell Proliferation
Cell Strain Hl 60
Cell Structure
Cell Viability
Concentration Response
Controlled Study
Depolarization
Dna Content
Dna Damage
Dna Fragmentation
Drug Effect
Drug Mechanism
Enzyme Activation
Genotoxicity
Human
Human Cell
Ic 50
Leukemia Cell
Membrane Potential, Mitochondrial
Mitochondrial Permeability
Mutagenic Activity
Oxidative Stress
Peripheral Blood Mononuclear Cell
Promyelocytic Leukemia
Antineoplastic Agents, Phytogenic
Apoptosis
Cell Proliferation
Cells, Cultured
Comet Assay
Cyclosporine
Cytokinesis
Dna Fragmentation
Hl-60 Cells
Humans
Inhibitory Concentration 50
Leukemia, Promyelocytic, Acute
Leukocytes, Mononuclear
Membrane Potential, Mitochondrial
Micronucleus Tests
Mitochondria
Mitochondrial Membrane Transport Proteins
Neoplasm Proteins
Quassins
Simaroubaceae
Picrolemma
Simaroubaceae
description Context: Quassinoids are biologically active secondary metabolites found exclusively in the Simaroubaceae family of plants. These compounds generally present important biological properties, including cytotoxic and antitumor properties. Objective: In the present study, the cytotoxic effects of neosergeolide, a quassinoid isolated from Picrolemma sprucei Hook. f., were evaluated in human promyelocytic leukemia cells (HL-60). Materials and methods: Cytotoxicity and antiproliferative effects were evaluated by the MTT assay, May-Grünwald-Giemsa's staining, BrdU incorporation test, and flow cytometry procedures. The comet assay and micronuclei analysis were applied to determine the genotoxic and mutagenic potential of neosergeolide. Results: After 24h exposure, neosergeolide strongly inhibited cancer cell proliferation (IC 50 0.1 μM), and its activity seemed to be selective to tumor cells because it had no antiproliferative effect on human peripheral blood mononuclear cells (PBMC) at tested concentrations. Apoptosis was induced at submicromolar concentrations (0.05, 0.1, and 0.2 μM) as evidenced by morphological changes, mitochondrial depolarization, phosphatidylserine externalization, caspases activation, and internucleosomal DNA fragmentation. Additionally, neosergeolide effects were prevented by cyclosporine A (CsA), an inhibitor of the mitochondrial permeability transition (MPT) pore, which reinforced the participation of intrinsic pathways in the apoptotic process induced by this natural quassinoid. Direct DNA damage was further confirmed by comet assay and cytokinesis-block micronucleus test. Discussion and conclusion: The present study provided experimental evidence to support the underlying mechanism of action involved in the neosergeolide-mediated apoptosis. In addition, no antiproliferative effect or DNA damage effect of neosergeolide was evident in PBMC, highlighting its therapeutic potential. © 2012 Informa Healthcare USA, Inc.
publishDate 2012
dc.date.issued.fl_str_mv 2012
dc.date.accessioned.fl_str_mv 2020-05-24T21:49:10Z
dc.date.available.fl_str_mv 2020-05-24T21:49:10Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio.inpa.gov.br/handle/1/16120
dc.identifier.doi.none.fl_str_mv 10.3109/13880209.2012.654921
url https://repositorio.inpa.gov.br/handle/1/16120
identifier_str_mv 10.3109/13880209.2012.654921
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Volume 50, Número 8, Pags. 980-993
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Pharmaceutical Biology
publisher.none.fl_str_mv Pharmaceutical Biology
dc.source.none.fl_str_mv reponame:Repositório Institucional do INPA
instname:Instituto Nacional de Pesquisas da Amazônia (INPA)
instacron:INPA
instname_str Instituto Nacional de Pesquisas da Amazônia (INPA)
instacron_str INPA
institution INPA
reponame_str Repositório Institucional do INPA
collection Repositório Institucional do INPA
bitstream.url.fl_str_mv https://repositorio.inpa.gov.br/bitstream/1/16120/1/artigo-inpa.pdf
bitstream.checksum.fl_str_mv 00f54b40fae7965294bff41217a581f3
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA)
repository.mail.fl_str_mv
_version_ 1797064371334021120